Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The significance of eosinophil and eosinophil lymphocyte ratio (ELR) in predicting response to omalizumab treatment in patients with severe allergic asthma.

Tuberkuloz ve toraks - 1 Mar 2021

Özgen Hasan, Tepetam Fatma Merve, Bulut İsmet, Örçen Cihan

Abstract excerpt

INTRODUCTION: Th2/Th1 mix pathological pathway may be seen as a common set of low eosinophilic phenotype in severe allergic asthma. This may affect omalizumab treatment response. In our study, we aimed to investigate whether eosinophil count (EOS) and percentage (EOS%), eosinophil lymphocyte ratio (ELR) and neutrophil lymphocyte ratio (NLR) may predict omalizumab treatment. MATERIALS AND METHODS: Patients who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Asthmatic Agents
Share to Asthma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Eosinophils

Share to Leukocyte Count

Share to Lymphocytes

Share to Neutrophils

Share to ROC Curve

Share to Treatment Outcome

Source

Identifiers

PMID: 33853304
DOI: 10.5578/tt.20219905

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The significance of eosinophil and eosinophil lymphocyte ratio (ELR) in predicting response to omalizumab treatment in patients with severe allergic asthma.PMID 33853304Read ↗

Influence of effective omalizumab treatment on eosinophils in allergic asthma with comorbiditiesSemantic proximity Read ↗

Severe asthma phenotypes in patients controlled with omalizumab: A real-world study.Semantic proximity Read ↗

Role of Eosinophil Granulocytes in Allergic Airway Inflammation Endotypes.Semantic proximity Read ↗

Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbiditiesSemantic proximity Read ↗

Comparison of the Effects of Second Generation Antihistamines and Omalizumab Treatment on Neutrophil / Lymphocyte Ratio, Platelet / Lymphocyte Ratio and Mean Platelet Volume in Patients with Chronic Spontaneous Urticaria with Each Other and with the Control GroupSemantic proximity Read ↗

Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness.Semantic proximity Read ↗

The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic AsthmaSemantic proximity Read ↗

Full blood count parameters for the detection of asthma inflammatory phenotypes.Semantic proximity Read ↗

The efficacy of omalizumab treatment in patients with non-atopic severe asthmaSemantic proximity Read ↗

Reslizumab in the treatment of severe eosinophilic asthma: an update.Semantic proximity Read ↗

Efficacy and Safety of Add-On Omalizumab in 4-6-Year-Old Children with Uncontrolled Allergic Asthma: A 52-Week Retrospective StudySemantic proximity Read ↗

Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.